The tweet was deleted by the author.
But we saved everything 🙂.
CVRx recognizes the important role of researchers and healthcare professionals who advance the science underpinning better patient care.
The company emphasized that clinical trials are essential for expanding treatment options, improving medical outcomes, and deepening the understanding of diseases and therapies. CVRx expressed gratitude to those working in clinical research. Details are being clarified.
Earlier this year, CVRx announced that Humana will provide Medicare Advantage coverage for Barostim therapy, expanding access to approximately 5.2 million Americans (link). The company also reported a 20 percent increase in total revenue for the first quarter, with a 22 percent gain in U.S. operations (link). These developments come as CVRx continues to support clinical research in its field.